326 related articles for article (PubMed ID: 23454900)
1. Molecular dissection of microsatellite instable colorectal cancer.
Vilar E; Tabernero J
Cancer Discov; 2013 May; 3(5):502-11. PubMed ID: 23454900
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
[TBL] [Abstract][Full Text] [Related]
3. [Molecular biology in clinical cancer research: the example of digestive cancers].
Lièvre A; Laurent-Puig P
Rev Epidemiol Sante Publique; 2005 Jun; 53(3):267-82. PubMed ID: 16227914
[TBL] [Abstract][Full Text] [Related]
4. [Occurrence, intratumoral heterogeneity, prognostic and predictive potential of microsatellite instability following surgical resection of primary colorectal carcinomas and corresponding liver metastases].
Ágoston EI; Baranyai Z; Dede K; Bodoky G; Kulka J; Bursics A; Harsányi L; Szász AM
Orv Hetil; 2015 Sep; 156(36):1460-71. PubMed ID: 26320600
[TBL] [Abstract][Full Text] [Related]
5. Role of microsatellite instability in the management of colorectal cancers.
Buecher B; Cacheux W; Rouleau E; Dieumegard B; Mitry E; Lièvre A
Dig Liver Dis; 2013 Jun; 45(6):441-9. PubMed ID: 23195666
[TBL] [Abstract][Full Text] [Related]
6. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
Marginean EC; Melosky B
Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability and therapeutic consequences in colorectal cancer.
Laghi L; Malesci A
Dig Dis; 2012; 30(3):304-9. PubMed ID: 22722556
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite instability in metastatic colorectal cancer: a review of pathology, response to chemotherapy and clinical outcome.
Yim KL
Med Oncol; 2012 Sep; 29(3):1796-801. PubMed ID: 21901450
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability.
Wielandt AM; Hurtado C; Moreno C M; Villarroel C; Castro M; Estay M; Simian D; Martinez M; Vial MT; Kronberg U; López-Köstner F
Tumour Biol; 2020 Jul; 42(7):1010428320938492. PubMed ID: 32635826
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of microsatellite instability in colorectal cancer.
Kloor M; Staffa L; Ahadova A; von Knebel Doeberitz M
Langenbecks Arch Surg; 2014 Jan; 399(1):23-31. PubMed ID: 24048684
[TBL] [Abstract][Full Text] [Related]
11. The implications of colorectal cancer molecular biology in clinical practice.
Kargozaran H; Kahlenberg M; Khatri VP
Surg Oncol Clin N Am; 2008 Apr; 17(2):341-55, viii-ix. PubMed ID: 18375356
[TBL] [Abstract][Full Text] [Related]
12. Interpretation of immunohistochemistry for mismatch repair proteins is only reliable in a specialized setting.
Overbeek LI; Ligtenberg MJ; Willems RW; Hermens RP; Blokx WA; Dubois SV; van der Linden H; Meijer JW; Mlynek-Kersjes ML; Hoogerbrugge N; Hebeda KM; van Krieken JH
Am J Surg Pathol; 2008 Aug; 32(8):1246-51. PubMed ID: 18677806
[TBL] [Abstract][Full Text] [Related]
13. Chr20q Amplification Defines a Distinct Molecular Subtype of Microsatellite Stable Colorectal Cancer.
Zhang B; Yao K; Zhou E; Zhang L; Cheng C
Cancer Res; 2021 Apr; 81(8):1977-1987. PubMed ID: 33619118
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability in the management of colorectal cancer.
Pino MS; Chung DC
Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):385-99. PubMed ID: 21651356
[TBL] [Abstract][Full Text] [Related]
15. Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer.
Zhang CM; Lv JF; Gong L; Yu LY; Chen XP; Zhou HH; Fan L
Int J Environ Res Public Health; 2016 Sep; 13(9):. PubMed ID: 27618077
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and molecular consequences of microsatellite instability in human cancers].
Hamelin R; Chalastanis A; Colas C; El Bchiri J; Mercier D; Schreurs AS; Simon V; Svrcek M; Zaanan A; Borie C; Buhard O; Capel E; Zouali H; Praz F; Muleris M; Fléjou JF; Duval A
Bull Cancer; 2008 Jan; 95(1):121-32. PubMed ID: 18230578
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and molecular characteristics of synchronous colorectal cancers: heterogeneity of clinical outcome depending on microsatellite instability status of individual tumors.
Bae JM; Cho NY; Kim TY; Kang GH
Dis Colon Rectum; 2012 Feb; 55(2):181-90. PubMed ID: 22228162
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between microsatellite instability and morphology in colorectal cancer].
Szentirmay Z; Gallai M; Serester O; Szoke J; Tóth E
Magy Onkol; 2010 Jun; 54(2):169-78. PubMed ID: 20576594
[TBL] [Abstract][Full Text] [Related]
20. The evolution of our molecular understanding of colorectal cancer: what we are doing now, what the future holds, and how tumor profiling is just the beginning.
Dienstmann R; Salazar R; Tabernero J
Am Soc Clin Oncol Educ Book; 2014; ():91-9. PubMed ID: 24857065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
